North America Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
North America Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $459.6 billion in 2022, representing a compound annual growth rate (CAGR) of 4.2% between 2017 and 2022.
- 0
- The US acquired an 88.8% share of the North American pharmaceuticals market in 2022. The FDA regulates the pharmaceutical industry in the US, approving 12% of drugs submitted for clinical testing annually. The rigorous clinical trial process results in additional spending on research and development.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the North America pharmaceuticals market by value in 2022?
- What will be the size of the North America pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up North America's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. AstraZeneca PLC
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. AstraZeneca PLC
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: North America pharmaceuticals market value: $ billion, 2017-22
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Johnson & Johnson: key facts
Table 5: Johnson & Johnson: Annual Financial Ratios
Table 6: Johnson & Johnson: Key Employees
Table 7: Johnson & Johnson: Key Employees Continued
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: Merck & Co., Inc.: key facts
Table 13: Merck & Co., Inc.: Annual Financial Ratios
Table 14: Merck & Co., Inc.: Key Employees
Table 15: Merck & Co., Inc.: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: AstraZeneca PLC: Key Employees Continued
Table 20: North America exchange rate, 2018-22
Table 1: North America pharmaceuticals market value: $ billion, 2017-22
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Johnson & Johnson: key facts
Table 5: Johnson & Johnson: Annual Financial Ratios
Table 6: Johnson & Johnson: Key Employees
Table 7: Johnson & Johnson: Key Employees Continued
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: Merck & Co., Inc.: key facts
Table 13: Merck & Co., Inc.: Annual Financial Ratios
Table 14: Merck & Co., Inc.: Key Employees
Table 15: Merck & Co., Inc.: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: AstraZeneca PLC: Key Employees Continued
Table 20: North America exchange rate, 2018-22
LIST OF FIGURES
Figure 1: North America pharmaceuticals market value: $ billion, 2017-22
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2022
Figure 1: North America pharmaceuticals market value: $ billion, 2017-22
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2022
